Choose a Lab Partner That is Always in Season

With over 25 years of experience, Ambry Genetics is deeply rooted in clinical excellence and trusted by healthcare providers nationwide. From our expertly-curated testing menu, to our broad patient access, we offer the clinical expertise, stability, and support you need to help your practice—and your patients—flourish.

Experienced.

Trusted.

25+ years in the genetics industry with a long history of innovative "firsts"
Peer-reviewed, published Gene-Disease (GDV) Validity scheme
Trusted by thousands of providers, including genetic counselors, oncologists, surgeons, and more

Easy-to-use.

Broad Patient Access.

Streamlined, flexible menu for easy and intuitive ordering
Digital ordering platforms for streamlined workflows
Broad patient access and transparent billing

Clinical Leaders.

Genomic Support.

400+ clinical and scientific professionals on-staff, including a team of Genomic Science Liaisons (GSLs) who are here to support you
Expertly curated panels guided by scientific evidence, clinical utility, and guidelines

What Else Sets Ambry Apart?

Ambry Classifi®

The Ambry Classifi program is a proprietary, knowledge-driven engine for gene classification, variant analysis & interpretation, and reporting, as well as our follow-up studies for resolving variants of unknown significance (VUS). But we don’t stop there: Classifi also embodies the way we share data, lead with expertise, and collaborate for the benefit of all.

Read Our Classifi White Paper

+RNAinsight®

+RNAinsight works concurrently with Ambry's DNA testing to identify patients with or at risk for hereditary cancer who might otherwise be missed, decrease variants of unknown significance in real-time, and provide more accurate results to inform patient care.

Review Our +RNAinsight Research Summary

There is No "one-size-fits-all" in Healthcare

And that applies to billing, too.

We strive to make genetic testing accessible and affordable for all patients.

Ambry is in-network with most U.S. health plans and will work with your patients' insurance to provide options for accessing our testing based on their individualized needs.

What's New From Ambry?

Check out the groundbreaking study featured in Nature that is already having a major impact on patients with a BRCA2 variant—moving them from uncertainty to clarity.